Literature DB >> 27324638

The Role of Metabolic Surgery on Blood Pressure Control.

Carlos Aurelio Schiavon1, Luciano F Drager2, Luiz A Bortolotto2, Celso Amodeo3, Dimas Ikeoka4, Otávio Berwanger4, Ricardo Vitor Cohen5.   

Abstract

Obesity and hypertension are growing epidemics in the modern world. Lifestyle changes and medical treatment for obesity have disappointing long-term results and albeit drugs for hypertension are usually very effective, the necessity of multiple pills and frequent side effects make the adherence to treatment a huge challenge for healthcare systems. Bariatric/metabolic surgery is a very effective treatment and an exponential number of studies have been showing its positive impact beyond weight loss, mainly on type 2 diabetes. There is also growing evidence suggesting that bariatric/metabolic surgery is associated with reduced incidence of cardiovascular events, but the impact on hypertension and other components of metabolic syndrome usually derive from trials' secondary end points. Taking this limitation in mind, bariatric/metabolic surgery action on blood pressure is reaching a significant proportion of hypertension resolution or improvement. In this review, we discussed the current evidence on the impact of bariatric/metabolic surgery on blood pressure control and pointed out perspectives in this research area.

Entities:  

Keywords:  Bariatric surgery; Blood pressure; Hypertension; Metabolic surgery; Roux-en-Y gastric bypass; Sleeve gastrectomy

Mesh:

Year:  2016        PMID: 27324638     DOI: 10.1007/s11883-016-0598-x

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


  36 in total

1.  Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial.

Authors:  Florencia Halperin; Su-Ann Ding; Donald C Simonson; Jennifer Panosian; Ann Goebel-Fabbri; Marlene Wewalka; Osama Hamdy; Martin Abrahamson; Kerri Clancy; Kathleen Foster; David Lautz; Ashley Vernon; Allison B Goldfine
Journal:  JAMA Surg       Date:  2014-07       Impact factor: 14.766

2.  Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Stacy A Brethauer; Sankar D Navaneethan; Ali Aminian; Claire E Pothier; Esther S H Kim; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2014-03-31       Impact factor: 91.245

3.  Body mass index and the prevalence of hypertension and dyslipidemia.

Authors:  C D Brown; M Higgins; K A Donato; F C Rohde; R Garrison; E Obarzanek; N D Ernst; M Horan
Journal:  Obes Res       Date:  2000-12

4.  Is type II diabetes mellitus (NIDDM) a surgical disease?

Authors:  W J Pories; K G MacDonald; E G Flickinger; G L Dohm; M K Sinha; H A Barakat; H J May; P Khazanie; M S Swanson; E Morgan
Journal:  Ann Surg       Date:  1992-06       Impact factor: 12.969

5.  Three-Year Outcomes of Bariatric Surgery vs Lifestyle Intervention for Type 2 Diabetes Mellitus Treatment: A Randomized Clinical Trial.

Authors:  Anita P Courcoulas; Steven H Belle; Rebecca H Neiberg; Sheila K Pierson; Jessie K Eagleton; Melissa A Kalarchian; James P DeLany; Wei Lang; John M Jakicic
Journal:  JAMA Surg       Date:  2015-10       Impact factor: 14.766

Review 6.  Safety and efficacy of bariatric surgery: Longitudinal Assessment of Bariatric Surgery.

Authors:  Steven H Belle; Paul D Berk; Anita P Courcoulas; David R Flum; Carolyn W Miles; James E Mitchell; Walter J Pories; Bruce M Wolfe; Susan Z Yanovski
Journal:  Surg Obes Relat Dis       Date:  2007 Mar-Apr       Impact factor: 4.734

Review 7.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

8.  Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity.

Authors:  Ricardo V Cohen; Jose C Pinheiro; Carlos A Schiavon; João E Salles; Bernardo L Wajchenberg; David E Cummings
Journal:  Diabetes Care       Date:  2012-07       Impact factor: 19.112

9.  Weight loss, saline loading, and the natriuretic peptide system.

Authors:  Pankaj Arora; Jason Reingold; Aaron Baggish; Derek P Guanaga; Connie Wu; Anahita Ghorbani; Yanna Song; Annabel Chen-Tournaux; Abigail May Khan; Laurel T Tainsh; Emmanuel S Buys; Jonathan S Williams; Denise M Heublein; John C Burnett; Marc J Semigran; Kenneth D Bloch; Marielle Scherrer-Crosbie; Christopher Newton-Cheh; Lee M Kaplan; Thomas J Wang
Journal:  J Am Heart Assoc       Date:  2015-01-16       Impact factor: 5.501

10.  Gastric bypass surgery is followed by lowered blood pressure and increased diuresis - long term results from the Swedish Obese Subjects (SOS) study.

Authors:  Peter Hallersund; Lars Sjöström; Torsten Olbers; Hans Lönroth; Peter Jacobson; Ville Wallenius; Ingmar Näslund; Lena M Carlsson; Lars Fändriks
Journal:  PLoS One       Date:  2012-11-29       Impact factor: 3.240

View more
  5 in total

1.  Reduction of Framingham BMI score after rapid weight loss in severely obese subjects undergoing sleeve gastrectomy: a single institution experience.

Authors:  David Gutierrez-Blanco; David Funes-Romero; SriGita Madiraju; Federico Perez-Quirante; Emanuele Lo Menzo; Samuel Szomstein; Raul J Rosenthal
Journal:  Surg Endosc       Date:  2017-08-25       Impact factor: 4.584

2.  Five-Year Outcomes After Vertical Sleeve Gastrectomy for Severe Obesity: A Prospective Cohort Study.

Authors:  Tone Nygaard Flølo; John R Andersen; Ronette L Kolotkin; Anny Aasprang; Gerd K Natvig; Karl O Hufthammer; Villy Våge
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

3.  Onco-Metabolic Surgery: A Combined Approach to Gastric Cancer and Hypertension.

Authors:  Dong Peng; Yu-Xi Cheng; Wei Tao; Ying-Ying Zou; Kun Qian; Wei Zhang
Journal:  Cancer Manag Res       Date:  2020-08-26       Impact factor: 3.989

4.  Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension).

Authors:  Carlos Aurelio Schiavon; Angela Cristine Bersch-Ferreira; Eliana Vieira Santucci; Juliana Dantas Oliveira; Camila Ragne Torreglosa; Priscila Torres Bueno; Julia Caldas Frayha; Renato Nakagawa Santos; Lucas Petri Damiani; Patricia Malvina Noujaim; Helio Halpern; Frederico L J Monteiro; Ricardo Vitor Cohen; Carlos H Uchoa; Marcio Gonçalves de Souza; Celso Amodeo; Luiz Bortolotto; Dimas Ikeoka; Luciano F Drager; Alexandre Biasi Cavalcanti; Otavio Berwanger
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

5.  Factors associated with hypertension remission after gastrectomy for gastric cancer patients.

Authors:  Bing Kang; Xiao-Yu Liu; Yu-Xi Cheng; Wei Tao; Dong Peng
Journal:  World J Gastrointest Surg       Date:  2022-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.